Kazano 12.5/1000 (as alogliptin benzoate 17 MG / metformin hydrochloride) Oral Tablet

RxCUI: 1368391
RxNorm name: Kazano 12.5/1000 (as alogliptin benzoate 17 MG / metformin hydrochloride) Oral Tablet
Display name: Kazano 12.5/1000 (as alogliptin benzoate 17 MG / metformin hydrochloride) Oral Tablet
Full name: Kazano 12.5/1000 (as alogliptin benzoate 17 MG / metformin hydrochloride) Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:06

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
KAZANO	ALOGLIPTIN AND METFORMIN HYDROCHLORIDE	Takeda Pharmaceuticals America, Inc.	83cb7914-a683-47bb-a713-f2bc6a596bd2	2025-05-30	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1368391

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
83cb7914-a683-47bb-a713-f2bc6a596bd2	Kazano 12.5/1000 (as alogliptin benzoate 17 MG / metformin hydrochloride) Oral Tablet	SY	21	These highlights do not include all the information needed to use KAZANO ® safely and effectively. See full prescribing information for KAZANO. KAZANO (alogliptin and metformin hydrochloride) tablets, for oral use Initial U.S. Approval: 2013	20250530
83cb7914-a683-47bb-a713-f2bc6a596bd2	alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet [Kazano]	SBD	21	These highlights do not include all the information needed to use KAZANO ® safely and effectively. See full prescribing information for KAZANO. KAZANO (alogliptin and metformin hydrochloride) tablets, for oral use Initial U.S. Approval: 2013	20250530
83cb7914-a683-47bb-a713-f2bc6a596bd2	Kazano 12.5 MG / 1000 MG Oral Tablet	PSN	21	These highlights do not include all the information needed to use KAZANO ® safely and effectively. See full prescribing information for KAZANO. KAZANO (alogliptin and metformin hydrochloride) tablets, for oral use Initial U.S. Approval: 2013	20250530
83cb7914-a683-47bb-a713-f2bc6a596bd2	Kazano 12.5/1000 Oral Tablet	SY	21	These highlights do not include all the information needed to use KAZANO ® safely and effectively. See full prescribing information for KAZANO. KAZANO (alogliptin and metformin hydrochloride) tablets, for oral use Initial U.S. Approval: 2013	20250530